{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Allergic contact dermatitis", "Drug candidate", "Glycolysis", "Herpetol", "T-lymphocytes"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27588913", "DateCompleted": {"Year": "2017", "Month": "05", "Day": "02"}, "DateRevised": {"Year": "2017", "Month": "05", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "08", "Day": "31"}], "ELocationID": ["10.1016/j.intimp.2016.08.025", "S1567-5769(16)30353-8"], "Language": ["eng"], "Journal": {"ISSN": "1878-1705", "JournalIssue": {"Volume": "40", "PubDate": {"Year": "2016", "Month": "Nov"}}, "Title": "International immunopharmacology", "ISOAbbreviation": "Int Immunopharmacol"}, "ArticleTitle": "Herpetol ameliorates allergic contact dermatitis through regulating T-lymphocytes.", "Pagination": {"StartPage": "131", "EndPage": "138", "MedlinePgn": "131-138"}, "Abstract": {"AbstractText": ["An immunosuppressant with fewer adverse effects is still urgently needed for increasing numbers of patients suffering from allergic contact dermatitis. In the present study, we aimed to investigate the immunosuppressive activity of herpetol on T-lymphocytes in vitro and in vivo and explore its potential pharmacological mechanism. The results showed that herpetol could effectively inhibit the proliferation of activated T cells and reduce the production of pro-inflammatory cytokines at 5-20\u03bcM. Additionally, the ear swelling and inflammatory responses induced by picryl chloride were significantly ameliorated by herpetol at 20-40mg/kg. Moreover, herpetol could cause cell cycle arrest of activated T cells in a dose-dependent manner. Furthermore, herpetol reduced the expression and activity of HIF-1\u03b1, Glut1 and LDHA, leading to glycolysis inhibition in activated T cells. Taken together, herpetol showed an immunosuppressive activity against T-cell mediated immune responses in vitro and in vivo, and it has potential for the treatment of immune-related skin diseases."], "CopyrightInformation": "Copyright \u00a9 2016 Elsevier B.V. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China."}], "LastName": "Li", "ForeName": "Xiang", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China; Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Sciences, Jiangsu Normal University, Xuzhou, China."}], "LastName": "Wang", "ForeName": "Xingqi", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China; School of Life Science and Engineering, and College of Medicine, Southwest Jiaotong University, Chengdu, China."}], "LastName": "Jiang", "ForeName": "Hezhong", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China."}], "LastName": "Zhang", "ForeName": "Guohui", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Science and Engineering, and College of Medicine, Southwest Jiaotong University, Chengdu, China."}], "LastName": "Tan", "ForeName": "Rui", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China."}], "LastName": "Sun", "ForeName": "Yang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China."}], "LastName": "Wu", "ForeName": "Xuefeng", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China. Electronic address: rxtan@nju.edu.cn."}], "LastName": "Tan", "ForeName": "Renxiang", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China. Electronic address: molpharm@163.com."}], "LastName": "Xu", "ForeName": "Qiang", "Initials": "Q"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Int Immunopharmacol", "NlmUniqueID": "100965259", "ISSNLinking": "1567-5769"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Benzofurans"}, {"RegistryNumber": "0", "NameOfSubstance": "Glucose Transporter Type 1"}, {"RegistryNumber": "0", "NameOfSubstance": "Hif1a protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoxia-Inducible Factor 1, alpha Subunit"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunosuppressive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Slc2a1 protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "herpetol"}, {"RegistryNumber": "Z4ZG7O5SZ9", "NameOfSubstance": "Picryl Chloride"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Benzofurans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Cycle"}, {"QualifierName": ["drug therapy", "immunology", "pathology"], "DescriptorName": "Dermatitis, Allergic Contact"}, {"QualifierName": ["pathology"], "DescriptorName": "Ear"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["genetics"], "DescriptorName": "Glucose Transporter Type 1"}, {"QualifierName": ["drug effects"], "DescriptorName": "Glycolysis"}, {"QualifierName": ["genetics"], "DescriptorName": "Hypoxia-Inducible Factor 1, alpha Subunit"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Immunosuppressive Agents"}, {"QualifierName": ["cytology"], "DescriptorName": "Lymph Nodes"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": [], "DescriptorName": "Picryl Chloride"}, {"QualifierName": ["cytology"], "DescriptorName": "Spleen"}, {"QualifierName": ["drug effects", "immunology", "metabolism"], "DescriptorName": "T-Lymphocytes"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2016", "Month": "4", "Day": "27"}, {"Year": "2016", "Month": "8", "Day": "23"}, {"Year": "2016", "Month": "8", "Day": "23"}, {"Year": "2016", "Month": "9", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "5", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "9", "Day": "3", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27588913", "10.1016/j.intimp.2016.08.025", "S1567-5769(16)30353-8"]}}], "PubmedBookArticle": []}